Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Seto

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Molecular Biotherapy|January 1, 1989
Immunohistochemical evidence for the production of tumor necrosis factor by murine MH134 tumor cells as well as monocytes in tumor lesions after systemic administration of a polyalcoholized mannoglucan from Microellobosporia griseaT Okutomi, K Dobashi, E Takano, et al.
British Journal of Cancer|September 22, 2005
UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trialY Ichinose, T Seto, H Semba, et al.
Acta Medica Okayama|October 1, 1990
A variant Philadelphia chromosome (Ph1) positive chronic myelocytic leukemiaY Haruta, I Takahashi, N Sekito, et al.
Lung Cancer (Amsterdam, Netherlands)|December 6, 2020
Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 studyN Yamamoto, T Seto, M Nishio, et al.
JCI Insight|April 17, 2019
Cullin-3 dependent deregulation of ACTN1 represents a new pathogenic mechanism in nemaline myopathyJordan Blondelle, Kavya Tallapaka, Jane T Seto, et al.
Nihon Gan Chiryo Gakkai Shi|August 20, 1979
[A new trial to progressed cancer of the pancreas with intraoperative radiotherapy (author's transl)]S Kawai, Y Kurata, E Sakamoto, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancerT Naito, T Seto, K Takeda, et al.
Human Mutation|October 4, 2018
Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and diseasePeter J Houweling, Ioannis D Papadimitriou, Jane T Seto, et al.
Angewandte Chemie (International Ed. in English)|November 23, 2017
Maximizing the Catalytic Activity of Nanoparticles through Monolayer Assembly on Nitrogen-Doped GrapheneChao Yu, Xuefeng Guo, Mengqi Shen, et al.
Toxicology Letters|October 8, 1999
Relationship between urinary cadmium and mortality among inhabitants living in a cadmium polluted area in JapanM Nishijo, H Nakagawa, M Morikawa, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Molecular Biotherapy|January 1, 1989
Immunohistochemical evidence for the production of tumor necrosis factor by murine MH134 tumor cells as well as monocytes in tumor lesions after systemic administration of a polyalcoholized mannoglucan from Microellobosporia griseaT Okutomi, K Dobashi, E Takano, et al.
British Journal of Cancer|September 22, 2005
UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trialY Ichinose, T Seto, H Semba, et al.
Acta Medica Okayama|October 1, 1990
A variant Philadelphia chromosome (Ph1) positive chronic myelocytic leukemiaY Haruta, I Takahashi, N Sekito, et al.
Lung Cancer (Amsterdam, Netherlands)|December 6, 2020
Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 studyN Yamamoto, T Seto, M Nishio, et al.
JCI Insight|April 17, 2019
Cullin-3 dependent deregulation of ACTN1 represents a new pathogenic mechanism in nemaline myopathyJordan Blondelle, Kavya Tallapaka, Jane T Seto, et al.
Nihon Gan Chiryo Gakkai Shi|August 20, 1979
[A new trial to progressed cancer of the pancreas with intraoperative radiotherapy (author's transl)]S Kawai, Y Kurata, E Sakamoto, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancerT Naito, T Seto, K Takeda, et al.
Human Mutation|October 4, 2018
Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and diseasePeter J Houweling, Ioannis D Papadimitriou, Jane T Seto, et al.
Angewandte Chemie (International Ed. in English)|November 23, 2017
Maximizing the Catalytic Activity of Nanoparticles through Monolayer Assembly on Nitrogen-Doped GrapheneChao Yu, Xuefeng Guo, Mengqi Shen, et al.
Toxicology Letters|October 8, 1999
Relationship between urinary cadmium and mortality among inhabitants living in a cadmium polluted area in JapanM Nishijo, H Nakagawa, M Morikawa, et al.
Pageof 24